News

Early detection and screening of breast cancer has allowed most women to thrive long after their diagnosis. However, women of color persistently experience disparities in outcomes. Researchers at the Kaiser Permanente Southern California Department of Research & Evaluation have been working to find ways to reduce these disparities and improve the survival rates for all ...

Amrita Mukherjee, PhD, MPH, is an epidemiologist in the first year of her postdoctoral program at the Kaiser Permanente Southern California Department of Research & Evaluation. Her research interests include human papillomavirus-associated cancers, gynecologic cancers, comorbidities in cancer patients and survivors, and development of risk prediction models using electronic health records and cancer registry data. ...

Adovich (Ado) Rivera, MD, PhD, is a health services researcher in the first year of his postdoctoral program at the Kaiser Permanente Southern California Department of Research & Evaluation. His research interests include studying disparities in chronic health disease outcomes, especially for people with HIV and sexual and gender minority populations. Before joining Kaiser Permanente, ...

A maternal and child health epidemiologist, Nana Mensah, PhD, MPH, is in the first year of her postdoctoral program at the Kaiser Permanente Southern California Department of Research & Evaluation. Through her research working with the Kaiser Permanente Southern California Pregnancy Registry, she seeks to understand how clinical guidelines and practices shape birth outcomes in ...

A health economist, Lewei Duan, PhD, MS, is a postdoctoral research fellow at the Kaiser Permanente Southern California Department of Research & Evaluation. She has special interests in improving health care delivery systems, specifically in maximizing health and well-being for older adults and underserved populations. Prior to her current position, Dr. Duan worked as a ...

A study of Kaiser Permanente Southern California members who were hospitalized for COVID-19 identifies key factors associated with lower chances of readmission — including treatment with the medication remdesivir and delaying discharge until 10 days have passed since COVID-19 symptoms began. “This study supports a continued role for remdesivir in treating COVID-19,” said the study’s lead ...

In a study of more than 10,000 Kaiser Permanente members diagnosed with both prostate cancer and depression, those who used antidepressants had a lower risk of cancer recurrence. These findings appeared September 9, 2022, in Cancer Causes & Control. “Our research highlights how important it is for patients with prostate cancer to be screened and treated ...

Patients who participated in in-home cardiac rehabilitation had fewer hospitalizations over 12 months than patients who participated in center-based cardiac rehabilitation, according to a Kaiser Permanente study published August 25, 2022, in JAMA Network Open. “The remarkable thing we found in this study of more than 2,500 diverse patients was that health advantages of home-based cardiac ...